Dermatol. praxi. 2018;12(4):199-203 | DOI: 10.36290/der.2018.032

Enterosorbent ENTEROSGEL in the complex treatment of atopic eczema

doc. MUDr. Jaromír Bystroň, CSc.1, MUDr. Lubomír Heller1, MUDr. Iva Karlová2, MUDr. Zora Poláčková2
1 Oddělení alergologie a klinické imunologie Fakultní nemocnice Olomouc
2 Klinika chorob kožních a pohlavních Fakultní nemocnice Olomouc

The authors present the results of a prospective, multicenter, controlled clinical trial that looked at the effect of ENTEROSGEL,the hydrogel of methyl silicic acid available as a medical device, in patients with moderate to severe atopic eczema. The authorsfollowed the symptom score in patients 15 days before dosing and 30 days of enterosorbent administration and within six monthsafter the end of dosing. At the same time, they evaluated the basic biochemical values of blood serum, tolerability and subjectiveevaluation of the effect of the studied product on individual patients. The primary endpoint of the study was confirmed in the19 subjects evaluated – there was a statistically significant reduction in the overall symptom score (by 1.7 points at p = 0.005)over a 30-day period. Monitoring of secondary endpoints (individual clinical and laboratory parameters monitored) confirmeda statistically significant improvement in the parameter – range of eczema deposits (P = 0.005). In laboratory findings, only aparameter-specific IgE-mite (p = 0.03) was statistically significant improvement. Other observed laboratory parameters were notstatistically significantly altered. In the analysis of the monitored parameters during the whole monitored period (ie, in days: -14,0, 30, 90, 180) there was a statistically significant change (improvement) in parameters – total symptom score (p < 0.001) both bystudy subjects (drop by 7.1 points) and by doctors (drop by 7 points). In similar analysis of the monitored parameters statisticallysignificant (p < 0.001) parameters – extent of disability, intensity of disability, feeling of itching, feeling of fatigue and lower levelof significance, digestive problems, local treatment and headache were statistically significant.

Keywords: enterosorbent, Enterosgel, atopic eczema

Published: December 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bystroň J, Heller L, Karlová I, Poláčková Z. Enterosorbent ENTEROSGEL in the complex treatment of atopic eczema. Dermatol. praxi. 2018;12(4):199-203. doi: 10.36290/der.2018.032.
Download citation

References

  1. Bystroň J, Heller L. Použití metody enterosorbční terapie pomocí organokřemičitého sorbentu ENTEROSGEL v komplexní léčbě alergických onemocnění. Alergie (Praha, Print). 2010, roč. 12, č. 2, s. 133-138. ISSN 1212-3536
  2. Sborník prací o využití preparátu ENTEROSGEL v medicíně (druhé a třetí vydání, část 1-7). Vydavatel: SILMA, a. s., Moskva, 2004-2007.
  3. Metodické doporučení klinického použití preparátu ENTEROSGEL u nemocných s chorobami trávicího traktu. Vydavatel: Ministerstvo zdraví Ruské federace, Moskva, 2000.
  4. Bystroň J, Heller L, Karlová I, Poláčková Z. Použití Enterosgelu v komplexní léčbě atopického ekzému. Alergie 2018,roč.20, č. 3, s. 193-198.




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.